We recently showed that the Wiskott-Aldrich syndrome protein (WASP) family member,WASH, localizes to endosomal subdomains and regulates endocytic vesicle scission in an Arp2/3-dependent manner. Mechanisms regulating WASH activity are unknown. Here we show that WASH functions in cells within a 500 kDa core complex containing Strumpellin, FAM21, KIAA1033 (SWIP), and CCDC53. Although recombinant WASH is constitutively active toward the Arp2/3 complex, the reconstituted core assembly is inhibited, suggesting that it functions in cells to regulate actin dynamics through WASH. FAM21 interacts directly with CAPZ and inhibits its actin-capping activity. Four of the five core components show distant (approximately 15% amino acid sequence identify) but significant structural homology to components of a complex that negatively regulates the WASP family member, WAVE. Moreover, biochemical and electron microscopic analyses show that the WASH and WAVE complexes are structurally similar. Thus, these two distantly related WASP family members are controlled by analogous structurally related mechanisms. Strumpellin is mutated in the human disease hereditary spastic paraplegia, and its link to WASH suggests that misregulation of actin dynamics on endosomes may play a role in this disorder.

Purpose: A few de novo missense variants in the cytoplasmic FMRP-interacting protein 2 (CYFIP2) gene have recently been described as a novel cause of severe intellectual disability, seizures, and hypotonia in 18 individuals, with p.Arg87 substitutions in the majority. Methods: We assembled data from 19 newly identified and all 18 previously published individuals with CYFIP2 variants. By structural modeling and investigation of WAVE-regulatory complex (WRC)-mediated actin polymerization in six patient fibroblast lines we assessed the impact of CYFIP2 variants on the WRC. Results: Sixteen of 19 individuals harbor two previously described and 11 novel (likely) disease-associated missense variants. We report p.Asp724 as second mutational hotspot (4/19 cases). Genotype–phenotype correlation confirms a consistently severe phenotype in p.Arg87 patients but a more variable phenotype in p.Asp724 and other substitutions. Three individuals with milder phenotypes carry putative loss-of-function variants, which remain of unclear pathogenicity. Structural modeling predicted missense variants to disturb interactions within the WRC or impair CYFIP2 stability. Consistent with its role in WRC-mediated actin polymerization we substantiate aberrant regulation of the actin cytoskeleton in patient fibroblasts. Conclusion: Our study expands the clinical and molecular spectrum of CYFIP2-related neurodevelopmental disorder and provides evidence for aberrant WRC-mediated actin dynamics as contributing cellular pathomechanism.

Purpose: A few de novo missense variants in the cytoplasmic FMRP-interacting protein 2 (CYFIP2) gene have recently been described as a novel cause of severe intellectual disability, seizures, and hypotonia in 18 individuals, with p.Arg87 substitutions in the majority. Methods: We assembled data from 19 newly identified and all 18 previously published individuals with CYFIP2 variants. By structural modeling and investigation of WAVE-regulatory complex (WRC)-mediated actin polymerization in six patient fibroblast lines we assessed the impact of CYFIP2 variants on the WRC. Results: Sixteen of 19 individuals harbor two previously described and 11 novel (likely) disease-associated missense variants. We report p.Asp724 as second mutational hotspot (4/19 cases). Genotype–phenotype correlation confirms a consistently severe phenotype in p.Arg87 patients but a more variable phenotype in p.Asp724 and other substitutions. Three individuals with milder phenotypes carry putative loss-of-function variants, which remain of unclear pathogenicity. Structural modeling predicted missense variants to disturb interactions within the WRC or impair CYFIP2 stability. Consistent with its role in WRC-mediated actin polymerization we substantiate aberrant regulation of the actin cytoskeleton in patient fibroblasts. Conclusion: Our study expands the clinical and molecular spectrum of CYFIP2-related neurodevelopmental disorder and provides evidence for aberrant WRC-mediated actin dynamics as contributing cellular pathomechanism.

Das 26S Proteasom führt die letzen Schritte des essentiellen, Ubiquitin abhängigen Proteinabbaus durch, indem es ubiquitinierte und fehlgefaltete Proteine erkennt und eliminiert. Da es in S. cerevisiae während allen Stadien der Zellteilung vornehmlich im Zellkern lokalisiert ist, ist der Importweg dieses 2,5 MDa umfassenden proteolytischen Komplexes in den Zellkern von besonderem Interesse. Das 26S Proteasom unterteilt sich in das katalytisch aktive 20S Proteasom sowie den 19S Regulatorkomplex. Für 20S Proteasomen konnten Lehmann und Mitarbeitende (2002, JMB, 317, 401) zeigen, dass Vorläuferkomplexe über den Karyopherin alpha/beta abhängigen Importweg in den Zellkern gelangen und dort zu 20S Proteasomen heranreifen. In dieser Arbeit wird gezeigt, dass die nukleäre Lokalisation der 19S Regulatorkomplexe ebenfalls von Karyopherin alpha/beta abhängt. Die Untersuchung der potentiellen klassischen Kernlokalisationssequenzen (cNLS) in den Untereinheiten des 19S Base Subkomplex ergab, dass Rpn2 und Rpt2, eine non-ATPase Untereinheit sowie eine ATPase Untereinheit des Base Komplex, funktionelle cNLS beherbergen. Die Deletion der Rpt2 NLS führte zur wt Lokalisation der proteasomalen Subkomplexe. Die Deletion der NLS in Rpn2 dagegen bewirkte eine verschlechterte proteasomale Funktion und eine Mislokalisation der Komplexe. Unsere Daten unterstützen ein Modell wonach die nukleären 26S Proteasomen aus Subkomplexen zusammengelagert werden, die durch Karyopherin alpha/beta in den Zellkern gelangen. / 26S proteasomes fulfil final steps in the ubiquitin-dependent degradation pathway by recognising and hydrolysing ubiquitylated proteins. As the 26S proteasome mainly localises to the nucleus in yeast, we addressed the question how this 2 MDa multisubunit complex is imported into the nucleus. 26S proteasomes consist of 20S proteolytically active core and 19S regulatory particles, the latter composed of two subcomplexes, namely the base and lid complexes. We have shown that 20S core particles are translocated into the nucleus as inactive precursor complexes via the classical karyopherin alpha/beta import pathway (Lehmann et al. 2002; JMB, 317, 401). Here, we provide evidence that nuclear import of base and lid complexes also depends on karyopherin alpha/beta. Potential classical nuclear localisation sequences (NLS) of base subunits were analysed. Rpn2 and Rpt2, a non-ATPase and an ATPase subunit of the base complex, harbour functional NLS. The Rpt2 NLS deletion yielded wild type localisation. However, the deletion of the Rpn2 NLS resulted in improper nuclear proteasome localisation and impaired proteasome function. Our data support the model by which nuclear 26S proteasomes are assembled from subcomplexes imported by karyopherin alpha/beta.

Das 20S Proteasom spielt zusammen mit seinem 19S Regulator als 26S Proteasomkomplex eine zentrale Rolle beim Abbau von Proteinen in eukaryotischen Zellen. Dem 19S Regulator wird dabei die Funktion der Substraterkennung und -entfaltung sowie die Beteiligung an der Translokation der entfalteten Substrate zum katalytischen Zentrum zugeordnet. In dieser Arbeit konnte erstmals gezeigt werden, daß der 19S Regulator chaperonähnliche Eigenschaften besitzt, dadurch also durchaus die Entfaltung der Proteinsubstrate bewirken kann. Durch den 19S Regulator war das 26S Proteasom in der Lage, einen Teil denaturierter Citratsynthase, eines Modellsubstrats für die Untersuchung von Chaperonaktivitäten, ATP-abhängig zum nativen Zustand zurückzufalten. Desweiteren führte die Anwesenheit des 19S Regulators bzw. des 26S Proteasoms in Abwesenheit von ATP zu einer Aggregationshemmung denaturierter Citratsynthase. Auch konnte die direkte Interaktion zwischen der Citratsynthase und dem 26S Proteasom bzw. dem 19S Regulator durch Glyceroldichtegradientenzentrifugation gezeigt werden. Diese chaperonähnlichen Eigenschaften des 19S Regulators konnten dem aus sechs ATPasen und zwei nicht-ATPasen bestehenden Base-Subkomplex zugeordnet werden. Aufgrund der Wechselwirkungen zwischen dem 19S Regulator und dem 20S Proteasom und damit möglicherweise verbundenen Konformationsänderungen in den Komplexen, wurde postuliert, daß der 19S Regulator auch auf die Biogenese, also die Assemblierung und Reifung des 20S Proteasoms einen Einfluß haben könnte. Es konnte gezeigt werden, daß Mutationen in den 19S ATPasen zu einer Anreicherung der unprozessierten proteasomalen 20S Untereinheit beta5 bei erhöhter Temperatur führen. Die Ursache dieses Anreicherungseffektes konnte nicht aufgeklärt werden. Der Effekt läßt sich nicht auf eine Hochregulation der m-RNA-Synthese der beta5-Untereinheit zurückführen. Die Beteiligung des 19S Regulators an frühen Assemblierungsstadien des 20S Proteasoms ist aufgrund der Analyse der mit dem Maturierungsfaktor Ump1 im Komplex vorliegenden Proteine ebenfalls unwahrscheinlich. Eine Beteiligung des 19S Regulators an einem der letzten Schritte der 20S Proteasomenbiogenese, beispielsweise an der Katalyse der Prozessierung der beta-Untereinheiten, ist eher vorstellbar, konnte aber nicht eindeutig gezeigt werden. Auf die Prozessierung der beta-Untereinheiten hat aber auch die katalytische Aktivität der beta-Untereinheiten einen nicht unwesentlichen Einfluß. So werden die katalytisch aktiven Untereinheiten durch Autokatalyse zu ihrer aktiven Form prozessiert und bewirken die Prozessierung der katalytisch inaktiven Untereinheiten beta6 und beta7. Dies konnte so auch durch Inaktivierung der beta2i-Untereinheit bestätigt werden. Die Expression der inaktiven Maus-beta1iT1A-Untereinheit in humanen T2-Zellinien verhinderte ihre eigene vollständige Prozessierung, hatte aber auch Einfluß auf die Prozessierung von beta7 und von inaktiv exprimierten beta1i (Maus-beta1iT1A). / In eukaryotic cells the protein degrading proteasome/ubiquitin system is involved in a wide variety of regulatory processes. The 26S proteasome is composed of two subcomplexes, a proteolytic core (20S) and a regulatory complex (19S). It is proposed that the proteins of the 19S regulatory complex can recognize and unfold the substrates. Furthermore the RC participates in translocation of the substrates into the proteasomes inner chamber were peptide bond hydrolysis occurs. This work shows that the proteasome exhibits an ATPdependent chaperon-like activity on citrate synthase, a model substrat for chaperones. Human and yeast proteasomes stimulated the recovery of the native structure of citrate synthase in an ATPdependent manner. Furthermore the 19S complex was able to supress the aggregation of denatured citrate synthase. Glycerol gradient analysis indicated that proteasome facilitates the refolding of citrate synthase through the formation of citrate synthase-proteasome complexes as expected for a chaperon-like mechanism. The chaperonlike activity was mapped to the base of the 19S regulatory complex. The RC could be able to unfold protein substrates in the 26S proteasome by this activity. The crystal structure of S. cerevisiae 20S proteasome shows a closed gate to the proteasome interiors. The 19S regulatory complex may induce conformational changes not only to open the protease cavity but also to assit in beta-subunit processing during 20S proteasome biogenesis. To test this hypothesis some yeast 19S ATPase mutant strains were analyzed for defective 20S proteasome maturation by following the processing of beta5-subunit. This work has shown that some mutations in these ATPases led to an accumulation of the unprocessed proteasomal beta5-subunit at restricted temperature. This effect was not due to the upregulation of beta5 mRNA transcription. It is not very likely that proteins of the RC participate in early steps of proteasome biogenesis, since they could not be found in precurser intermediates containing the maturation factor Ump1p. However, they might be important for later assembly steps. During biogenesis five prosequence containing beta subunits have to be processed. This proceeds via a two-step mechanism involving autocatalytic or transcatalytic processing by neighbouring subunits. The proposed mechanism could be confirmed by inactivation of the beta2i subunit via substitution of the active site Threonin1 against Alanin (beta2iT1A). The inactivation blocked the autocatalysis of beta2i and influenced the processing of beta7 and that of inactivated beta1i (beta1iT1A).

O presente estudo aborda a introdução de ações de regulação na gestão de saúde de um município do interior do estado do Rio de Janeiro, de 2009 a 2012. Mais especificamente, são analisadas a responsabilização sanitária do ente municipal a partir da aquisição da gestão plena do sistema (Pacto de Gestão) e as ações desencadeadas pela implantação do Controle, Avaliação e Auditoria, e pela criação do Complexo Regulador, tendo como referência a Política Nacional de Regulação. A metodologia empregada envolveu análise documental e entrevistas com informantes-chave. Os resultados demonstram o desenvolvimento de ações em todas as dimensões da regulação e o amadurecimento da função reitora da secretaria municipal de saúde sobre o sistema, através do direcionamento qualitativo e quantitativo dos prestadores privados. / The present study focus on the introduction of regulatory actions on health management in a municipality of the state of Rio de Janeiro, 2009-2012. More specifically, it analyses the new health responsibility taken by the municipal administration after acquiring the full management of the system (Management Pact) and the actions triggered by the implementation of control, evaluation and auditing, as well the creation of a regulatory complex, with reference to regulation national policy. The methodology included documental analysis and interviews with key informants. The results demonstrated the implementation of actions in all aspects of regulation and the progress of the local health system stewardship function at the municipal health department through the qualitative and quantitative guidance on the private providers.

O presente estudo aborda a introdução de ações de regulação na gestão de saúde de um município do interior do estado do Rio de Janeiro, de 2009 a 2012. Mais especificamente, são analisadas a responsabilização sanitária do ente municipal a partir da aquisição da gestão plena do sistema (Pacto de Gestão) e as ações desencadeadas pela implantação do Controle, Avaliação e Auditoria, e pela criação do Complexo Regulador, tendo como referência a Política Nacional de Regulação. A metodologia empregada envolveu análise documental e entrevistas com informantes-chave. Os resultados demonstram o desenvolvimento de ações em todas as dimensões da regulação e o amadurecimento da função reitora da secretaria municipal de saúde sobre o sistema, através do direcionamento qualitativo e quantitativo dos prestadores privados. / The present study focus on the introduction of regulatory actions on health management in a municipality of the state of Rio de Janeiro, 2009-2012. More specifically, it analyses the new health responsibility taken by the municipal administration after acquiring the full management of the system (Management Pact) and the actions triggered by the implementation of control, evaluation and auditing, as well the creation of a regulatory complex, with reference to regulation national policy. The methodology included documental analysis and interviews with key informants. The results demonstrated the implementation of actions in all aspects of regulation and the progress of the local health system stewardship function at the municipal health department through the qualitative and quantitative guidance on the private providers.